This HTML5 document contains 116 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n7http://dx.doi.org/10.1161/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q45143057
rdf:type
wikibase:Item
schema:description
artykuł naukowy naučni članak artikel ilmiah artikull shkencor teaduslik artikkel tieteellinen artikkeli article científic 2004年学术文章 επιστημονικό άρθρο bilimsel makale vedecký článok 2004年學術文章 artigo científico vitenskapelig artikkel scientific article published on 7 November 2004 научная статья სამეცნიერო სტატია مقالة علمية نشرت في 7 نوفمبر 2004 videnskabelig artikel 2004 nî lūn-bûn научни чланак articol științific wissenschaftlicher Artikel tudományos cikk מאמר מדעי artigo científico 2004年學術文章 vitskapeleg artikkel 2004年学术文章 2004年学术文章 2004年學術文章 научни чланак ৭ নভেম্বর ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vědecký článek artículu científicu scientific article published on 7 November 2004 научна статия vetenskaplig artikel bài báo khoa học articolo scientifico 2004년 논문 artikulong pang-agham wetenschappelijk artikel 2004年学术文章 наукова стаття, опублікована в листопаді 2004 artigo científico 2004年學術文章 2004年学术文章 artículo científico publicado en 2004 article scientifique article scientific 2004 թվականի նոյեմբերի 7-ին հրատարակված գիտական հոդված scientific article published on 7 November 2004 2004年學術文章 2004年学术文章 บทความทางวิทยาศาสตร์ 2004年の論文 мақолаи илмӣ scienca artikolo
p:P577
wds:Q45143057-F3F9DF94-2D04-4CC5-9FBD-93B495D83CCF
wdt:P577
2004-11-07T00:00:00Z
p:P407
wds:Q45143057-3B40CE93-96E3-4ED9-A0FF-B06D0524E5C9
wdt:P407
wd:Q1860
p:P2093
wds:Q45143057-6BA2011E-070B-432B-AD85-A556F03D9AC8 wds:Q45143057-FDBD3FBB-DD3E-48AE-9669-D13C5C2DEC8E wds:Q45143057-415EDEE2-A87D-4C72-A98C-13D6648C114B wds:Q45143057-2B300071-8789-47A9-9262-FF18C3E5F716 wds:Q45143057-EF7BAFD7-1D71-4571-8735-8B8721E26972 wds:Q45143057-D544A2B8-DCC7-4B36-869A-CCC5DBFF2CF7 wds:Q45143057-B81FD89A-DC5A-4C29-8249-909520C68F09 wds:Q45143057-B5A6FE85-30D2-409F-B343-A7ACD4A48BAD
wdt:P2093
Peter P Berger Intracoronary Stenting and Antithrombotic Regimen: Is Abciximab a Superior Way to Eliminate Elevated Thrombotic Risk in Diabetics (ISAR-SWEET) Study Investigators Franz Dotzer Helmut Schühlen Jürgen Pache Alban Dibra Josef Dirschinger Hildegard Bollwein
rdfs:label
Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel
skos:prefLabel
Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel
schema:name
Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel
p:P50
wds:Q45143057-9AC89765-A4C9-4FCD-99BB-1A704560F76B wds:Q45143057-5FA5FE51-5C11-48D3-B773-6DE8C0D6F981 wds:Q45143057-65AF70F1-2D62-4E55-89A5-9A08B7CC4825 wds:Q45143057-0C9B117C-4A7D-4140-9A87-88138CA596E7
wdt:P50
wd:Q43249625 wd:Q63253406 wd:Q63253291 wd:Q63253283
p:P1476
wds:Q45143057-73B5E19A-028B-4101-807C-EF4117D2FCE6
wdt:P1476
Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel
p:P304
wds:Q45143057-65AC83E8-1F6D-49A8-8E01-84BF880DF90C
wdt:P304
3627-3635
p:P31
wds:Q45143057-4B5D3833-CC07-4D94-8918-9DF94F08A049
wdt:P31
wd:Q13442814
p:P921
wds:Q45143057-0C1CB811-1D36-4BE2-87A4-F2A294E0E3FE wds:Q45143057-B1FDA04E-BA05-4AE5-85E2-CB070BC48B47
wdt:P921
wd:Q181600 wd:Q410237
p:P698
wds:Q45143057-3F05046D-19C1-4DD7-ADC7-A60155FD7C3F
wdtn:P698
n11:15531766
wdt:P698
15531766
p:P1433
wds:Q45143057-AC857525-E557-46A9-8E1C-317553BF6F6E
wdt:P1433
wd:Q578091
p:P433
wds:Q45143057-BA47CD01-1699-43FB-8654-EDA81892F24E
p:P478
wds:Q45143057-A285BDE1-24D8-4BB1-A5AC-27781FE7394E
wdt:P433
24
wdt:P478
110
p:P356
wds:Q45143057-C80846C1-D9B3-4F89-A4FC-5633514FD96A
wdtn:P356
n7:01.CIR.0000148956.93631.4D
wdt:P356
10.1161/01.CIR.0000148956.93631.4D